Latest News
Amid satellite-disruption fears hitting telecoms, T-Mobile's spectrum swaps, SpaceX partnership, and enterprise push support analyst upgrades and a premium valuation versus AT&T and Verizon.
Via MarketBeat · July 14, 2026
Others are likely to perform better, but it may be a good addition to your portfolio.
Via The Motley Fool · July 14, 2026
TSMC's June revenue report suggests that the stock is poised for bigger gains in the second half of 2026.
Via The Motley Fool · July 14, 2026
The stock is poised to push beyond its $5.1 trillion market value.
Via The Motley Fool · July 14, 2026
The opportunity behind these recently raised funds is nothing less than amazing.
Via The Motley Fool · July 14, 2026
Rockwell Automation, Cognex, and Teradyne posted strong earnings amid rising AI-driven factory automation demand, with analysts largely maintaining Buy ratings and upside price targets on all three stocks.
Via MarketBeat · July 14, 2026
As data centers strain water systems, FIW, PHO, and CGW offer investors ETF-based access to water utilities, infrastructure, and equipment firms, each with distinct fees and concentration.
Via MarketBeat · July 14, 2026
The pharma giant's yield of around 7.1% is more than six times the S&P 500 average.
Via The Motley Fool · July 14, 2026
There are two different ways to interpret Meta Platforms' apparent plans to start leasing its spare cloud capacity.
Via The Motley Fool · July 14, 2026
The electricity demand from data centers is straining the power grid and pushing power prices higher, leading to unpaid utility bills.
Via The Motley Fool · July 14, 2026
Rogers Communications (TSX:RCI.B) stock is taking a beating again, but its dividend remains on safe footing.
Via The Motley Fool · July 14, 2026
That's not a bad thing at all.
Via The Motley Fool · July 14, 2026
Maintaining robust structural health is fundamental to sustaining a high quality of life. However, when complex illnesses develop within the kidneys, bladd
Via Talk Markets · July 14, 2026
Since the start of July, the Chinese tech stock has risen by 17%.
Via The Motley Fool · July 14, 2026
IntroductionSoftware delivery slows down when development and operations work through separate handoffs, manual deployment steps, and unclear ownership. A
Via Talk Markets · July 14, 2026
Amazon's $25 billion bond raise saw weaker-than-average demand and wider concessions, a subtle signal bond markets may be growing cautious on hyperscalers' heavy AI-driven debt spending.
Via MarketBeat · July 14, 2026
Bank of America (NYSE:BAC) reported broad-based second-quarter growth, with management pointing to stronger net interest income, fee revenue, client activity and operating leverage across each of its business segments.
CEO Brian Moynihan said the bank generated revenue of $31.6 billion, up 15% from
Via MarketBeat · July 14, 2026
JPMorgan Chase & Co. (NYSE:JPM) reported second-quarter 2026 net income of $16.9 billion, earnings per share of $6.14 and a return on tangible common equity of 23%, Chief Financial Officer Jeremy Barnum said on the bank’s earnings call.
Excluding significant items noted in the company’s present
Via MarketBeat · July 14, 2026
Peach Salad Recipe: Fresh, Healthy, and Delicious Summer FavoriteDiscover the best Peach Salad recipe with fresh peaches, greens, feta, and a delicious hom
Via Talk Markets · July 14, 2026
Cathie Wood's biotech ETF has largely moved on from the vaccine maker.
Via The Motley Fool · July 14, 2026
The Sodium Chlorite price trend during Q1 reflected a balanced market influenced by raw material costs, industrial demand, and global supply chain conditio
Via Talk Markets · July 14, 2026
Calance is a global IT services firm that helps pharmaceutical and life sciences organizations modernize how they plan, run, and monitor clinical research.
Via Talk Markets · July 14, 2026
Constellation Software stock has dropped 44% from its highs, but Q1 numbers show why long term investors should be paying attention now.
Via The Motley Fool · July 14, 2026
Many people begin a weight loss programme with one important question: Will the results last? While treatments like Mounjaro and Wegovy have changed the wa
Via Talk Markets · July 14, 2026
It's in an even more elite tier than the Dividend Kings.
Via The Motley Fool · July 14, 2026